Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Chile
100%
Mesenchymal Stem Cells
86%
Bipolar Disorder
55%
Chilean
54%
Preeclampsia
33%
Exosomes
27%
COVID-19
25%
Cell-based
23%
Postsynaptic Density Protein 95 (PSD-95)
22%
Invasive Pneumococcal Disease
22%
Pregnant Women
20%
T Helper 17 (Th17)
18%
Confidence Interval
18%
Endometrial Stem Cells
17%
Cell Therapy
16%
Mesenchymal Stromal Cells
16%
Antidepressants
15%
MicroRNA
15%
Immunization
14%
Latin America (LATAM)
14%
Infectious Diseases
14%
Small Extracellular Vesicles
14%
Fluoxetine
14%
Extracellular Vesicles
14%
Rheumatoid Arthritis
13%
Human Mesenchymal Stem Cells (hMSCs)
13%
Quantitative PCR
13%
Therapeutic Potential
12%
Santiago De Chile
12%
Hypertension
12%
Vaccination
12%
Astrocytes
12%
Inducible Nitric Oxide Synthase
12%
Systemic Lupus Erythematosus
11%
T Cells
11%
Chronic Kidney Disease
11%
Noncardiac Surgery
11%
Selective Intrauterine Growth Restriction (sIUGR)
11%
Stem Cells
11%
Placebo
10%
Universidad
10%
Hypoxia
10%
Obesity
10%
PCV10
9%
Acute Respiratory Distress Syndrome
9%
Pharmacogenomics
9%
Gestational Diabetes Mellitus
9%
Spironolactone
9%
Gestational Age
9%
Chronic Dialysis
9%
Risk Factors
9%
Ischemia-reperfusion Injury
9%
Fetus
9%
N-methyl-D-aspartate Receptor (NMDAR)
9%
Regulatory T (Treg) Cells
9%
13-valent Pneumococcal Conjugate Vaccine (PCV13)
8%
Experimental Autoimmune Encephalomyelitis
8%
Clostridioides Difficile
8%
Inflammation
8%
First Trimester
8%
Neisseria Meningitidis
8%
Meta-analysis
8%
TrkB
8%
Epidemiology
8%
Synaptic Plasticity
8%
Forebrain
8%
Biomaterials
8%
Andes
8%
Cell-free Fetal DNA
8%
Mitochondria
8%
Placenta
8%
Nuclear Factor of Activated T-cells 5
8%
Nitric Oxide
7%
Acute Kidney Injury
7%
Odds Ratio
7%
NF-B
7%
Interleukin-17 (IL-17)
7%
Body Mass Index
7%
Mitochondrial Transfer
7%
Fecal Microbiota Transplantation
7%
Allogeneic
7%
Angiogenesis
7%
Kidney
7%
Hemodialysis
7%
Clinical Features
7%
Cardiovascular Disease
7%
Tumor Necrosis Factor-α
7%
Early Pregnancy
7%
Stem Cell Therapy
7%
Cell-to-cell
7%
Maternal Plasma
7%
Myocardial Infarction
7%
Chronic Hemodialysis
7%
Therapeutic Properties
7%
Rat Model
7%
Major Depressive Disorder
7%
Randomized Clinical Trial
7%
Streptococcus Pneumoniae
7%
Pneumococcal Conjugate Vaccine
7%
Ischemia Injury
7%
Medicine and Dentistry
Disease
50%
Mesenchymal Stem Cell
36%
Infection
31%
Bipolar Disorder
28%
Stem Cell
27%
COVID-19
25%
Pre-Eclampsia
24%
Serotype
22%
First Trimester Pregnancy
18%
Public Health
18%
Meningococcal Disease
17%
Cell Therapy
16%
Pneumococcus Vaccine
15%
Systematic Review
15%
Prevalence
14%
Cohort Analysis
14%
Noncardiac Surgery
14%
Gestational Age
13%
Pediatrics
13%
Peritoneal Dialysis
13%
Neonatal Infant
11%
Biological Marker
11%
Severe Acute Respiratory Syndrome Coronavirus 2
10%
Hypotension
9%
Apoplexy
9%
Intrauterine Growth Retardation
9%
Acute Respiratory Distress Syndrome
9%
Acute Kidney Injury
9%
Systemic Lupus Erythematosus
9%
Diagnosis
9%
Cohort Effect
9%
Quality of Life
8%
Mortality Rate
8%
Clinical Trial
8%
Ischemia
8%
Adolescence
8%
Placebo
8%
Stromal Cell
8%
Exosome
8%
Messenger RNA
8%
Cardiovascular Disease
8%
Cardiovascular System
7%
Maturity Onset Diabetes of the Young
7%
Case-Control Study
7%
Cesarean Section
7%
Randomized Clinical Trial
7%
In Vitro
7%
Chronic Kidney Disease
7%
Health Care Cost
7%
Meta-Analysis
7%
Rheumatic Heart Disease
7%
Anemia
7%
Umbilical Cord
7%
Urinary System
7%
Hemodialysis
7%
Injury
7%
Bleeding
6%
Maternal Plasma
6%
Pregnancy
6%
Gestational Diabetes
6%
Female Fertility
6%
Fibroblast Growth Factor 23
6%
Knee Arthroplasty
6%
Fecal Microbiota Transplantation
6%
Drug Therapy
6%
Pneumococcal Infection
6%
Body Mass Index
6%
Rheumatic Fever
6%
Randomized Controlled Trial
6%
Athletes
6%
Medicine
6%
Primary Health Care
6%
Oxidative Stress
5%
Prematurity
5%
Premature Labor
5%
Angiogenesis
5%
Receptor
5%
Cost-Effectiveness Analysis
5%
Placenta
5%
Thrombocyte Poor Plasma
5%
Breast Cancer
5%
Trophoblast
5%
Bone Marrow Derived Mesenchymal Stem Cell
5%
Neutrophil Gelatinase Associated Lipocalin
5%
Surgery
5%